VDPHL01 — Full data
H2 2026
Twelve-month data from Study ‘302' are anticipated in the second half of 2026.Source filing
MANE biotech catalysts & pipeline
VERADERMICS INC · Data as of 2026-10-25
Upcoming catalysts
VDPHL01 — Topline data
H1 2027
Veradermics also announced in August completion of participant enrollment for its female pattern hair loss Phase 2/3 trial, Study ‘306', with a readout of topline data anticipated in the first half of 2027.Source filing